FGEN MEXC RealStocks
Own real FGEN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:26:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
FibroGen, Inc. (FGEN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
FibroGen, Inc. (FGEN) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.
After-hours trading shows how investors are pricing FGEN after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.
Over the past seven days, FibroGen, Inc. (FGEN) moved from $8.76 to $9.71, representing a gain of 10.84% ($0.95).
The stock traded between $8.50 and $9.75 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 27.10 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 225 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for FibroGen, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of FibroGen, Inc. (FGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to FGEN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between FGEN shares and USD.
FGEN Shares to USD
1.00 FGEN shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.